Top-News

ADC Therapeutics Aktie News

Aktie
WKN:  A2PSR8 ISIN:  CH0499880968 US-Symbol:  ADCT Branche:  Biotechnologie Land:  Schweiz
3,29 $
-0,25 $
-7,06%
2,8255 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
337,96 Mio. €
Streubesitz
27,10%
KGV
-1,33
Index-Zuordnung
-

ADC Therapeutics News

03.12.25 - PR Newswire
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-​in-Class ...
02.12.25 - PR Newswire
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial PR Newswire
01.12.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
10.11.25 - PR Newswire
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update PR Newswire
03.11.25 - PR Newswire
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025 PR Newswire
27.10.25 - PR Newswire
ADC Therapeutics to Present at November Investor Conferences
ADC Therapeutics to Present at November Investor Conferences PR Newswire
13.10.25 - PR Newswire
ADC Therapeutics Announces $60 Million Private Placement
ADC Therapeutics Announces $60 Million Private Placement PR Newswire
01.10.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
02.09.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
27.08.25 - PR Newswire
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 PR Newswire
12.08.25 - PR Newswire
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update PR Newswire
05.08.25 - PR Newswire
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 PR Newswire
01.08.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
01.07.25 - PR Newswire
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
16.06.25 - PR Newswire
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-​Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant ...
12.06.25 - PR Newswire
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 PR Newswire
12.06.25 - PR Newswire
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress PR Newswire
02.06.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »